Axon degeneration is an active, evolutionarily conserved selfdestruction program by which compromised axons fragment in response to varied insults. Unlike programmed cell death, axon degeneration is poorly understood. We have combined robotic liquid handling with automated microscopy and image analysis to create a robust screening platform to measure axon degeneration in mammalian primary neuronal cultures. Using this assay, we performed an unbiased screen of 480 bioactive compounds, identifying 11 that reproducibly delay fragmentation of severed axons in vitro, including two inhibitors of glycogen synthase kinase 3 and two inhibitors of IB kinase. Knockdown of each of these targets by shRNA lentivirus also delays axon degeneration in vitro, further supporting their role in the axon degeneration program.The axon is a uniquely neuronal structure whose specialized architecture facilitates the rapid transmission of information across long distances. Just as compromised cells undergo programmed cell death, damaged axons undergo an active selfdestruct process that involves cytoskeletal disassembly, swelling, and eventual fragmentation with no concomitant cell death (1, 2). This process has been broadly termed axon degeneration and is intrinsic to the neuron. Despite their resemblance, axon degeneration and apoptosis are largely mechanistically distinct (1, 3); however, axon and dendrite breakdown in the contexts of developmental pruning or trophic withdrawal does involve caspases and other apoptotic machinery (5,6,21). Components of the axon degeneration cascade include calpain proteases and the ubiquitin-proteasome system, and calcium influx is also an important step (7-9). Axon degeneration is thought to be an early, important step in the pathologic progression and morbidity in diseases of the peripheral and central nervous systems including diabetic neuropathy, Parkinson disease, and multiple sclerosis (1, 2). Clearly, understanding the mechanisms that promote axon degeneration could have therapeutic value, yet little is known regarding the mechanisms by which axons commit to and execute this program of self-destruction.Unbiased high-content screening is a powerful approach for uncovering biological signaling cascades. Here, we report an image-based screening assay that combines automated microscopy, liquid handling, and image analysis of primary cultured neurons to screen for experimental conditions that delay or suppress axon degeneration following axotomy. Using this assay, we identified 11 compounds from a library of 480 that delay degeneration of severed axons in vitro in a dose-dependent manner. Among these, several have biologic targets with previously reported involvement in axon degeneration, however, our findings also reveal that inhibitors of IB kinase (IKK) 2 and glycogen synthase kinase 3 (GSK3) suppress axotomy-induced axon degeneration. Finally, we demonstrate through shRNA-mediated knockdown that IKK and GSK3 are required to promote rapid axon degeneration.
EXPERIMENTAL PROCEDURESDRG Neuron Culture...